Adrenoceptor subtype-specific acceleration of the hypoxic depression of excitatory synaptic transmission in area CA1 of the rat hippocampus

European Journal of Neuroscience

Volumn 20, Issue 6, 2004, Pages 1555-1565

  Pearson, Tim ^a   Frenguelli, Bruno G ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Adenosine; Biosensor; Hypoxia; Ischemia; Noradrenaline; Sensor

Indexed keywords

6 FLUORONORADRENALIN; ADENOSINE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 1 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BETAXOLOL; ISOPRENALINE; NORADRENALIN; PROPRANOLOL; RECEPTOR SUBTYPE; URAPIDIL; YOHIMBINE;

ANIMAL TISSUE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; BRAIN HYPOXIA; CONTROLLED STUDY; EXTRACELLULAR SPACE; FEMALE; HIPPOCAMPUS; MALE; NONHUMAN; PHARMACOLOGICAL STIMULATION; PRIORITY JOURNAL; RAT; SYNAPTIC INHIBITION; SYNAPTIC TRANSMISSION;

ADENOSINE; ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-AGONISTS; ANIMALS; ANIMALS, NEWBORN; ANOXIA; ANTIOXIDANTS; ASCORBIC ACID; DRUG INTERACTIONS; EXCITATORY POSTSYNAPTIC POTENTIALS; FEMALE; HIPPOCAMPUS; ISOPROTERENOL; MALE; NEURAL INHIBITION; NEURONS; NOREPINEPHRINE; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A1; SYNAPTIC TRANSMISSION; TIME FACTORS; YOHIMBINE;

EID: 4644278775     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2004.03602.x     Document Type: Article

References (85)

1. 1 receptors located on noradrenergic nerve terminals. Naunyn Schmiedebergs Arch. Pharmacol., 344, 187-192.
2. Altenburg, S.P. & Farah, M.B. (1999) Tizanidine protects mice against convulsions induced by lidocaine: involvement of alpha 2-adrenoceptors. Pharmacol. Toxicol., 84, 29-33.
3. Anderson, W.W. & Collingridge, G.L. (2001) The LTP Program: a data acquisition program for on-line analysis of long-term potentiation and other synaptic events. J. Neurosci. Meth., 108, 71-83.
4. Bennett, H.J., White, T.D. & Semba, K. (2000) Activation of metabotropic glutamate receptors increases extracellular adenosine in vivo. Neuroreport, 11, 3489-3492.
5. Bennett, H.J., White, T.D. & Semba, K. (2003) Activation of cholinergic and adrenergic receptors increases the concentration of extracellular adenosine in the cerebral cortex of unanesthetized rat. Neuroscience, 117, 119-127.
6. Benveniste, H., Drejer, J., Schousboe, A. & Diemer, N.H. (1984) Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem., 43, 1369-1374.
7. Bergles, D.E., Doze, V.A., Madison, D.V. & Smith, S.J. (1996) Excitatory actions of norepinephrine on multiple classes of hippocampal CA1 interneurons. J. Neurosci., 16, 572-585.
8. Bickler, P.E. & Hansen, B.M. (1996) Alpha 2-adrenergic agonists reduce glutamate release and glutamate receptor-mediated calcium changes in hippocampal slices during hypoxia. Neuropharmacology, 35, 679-687.
9. Boehm, S. (1999) Presynaptic alpha2-adrenoceptors control excitatory, but not inhibitory, transmission at rat hippocampal synapses. J. Physiol. (Lond.), 519, 439-449.
10. Brundege, J.M. & Dunwiddie, T.V. (1997) Role of adenosine as a modulator of synaptic activity in the central nervous system. Adv. Pharmacol., 39, 353-391.
11. Brundege, J.M., Diao, L., Proctor, W.R. & Dunwiddie, T.V. (1997) The role of cyclic AMP as a precursor of extracellular adenosine in the rat hippocampus. Neuropharmacology, 36, 1201-1210.
12. Bylund, D.B., Eikenberg, D.C., Hieble, J.P., Langer, S.Z., Lefkowitz, R.J., Minneman, K.P., Molinoff, P.B., Ruffolo, R.R. Jr & Trendelenburg, U. (1994) International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol. Rev., 46, 121-136.
13. Coelho, J.E., de Mendonça, A. & Ribeiro, J.A. (2000) Presynaptic inhibitory receptors mediate the depression of synaptic transmission upon hypoxia in rat hippocampal slices. Brain Res., 869, 158-165.
14. Culmsee, C., Junker, V., Kremers, W, Thal, S., Plesnila, N. & Krieglstein, J. (2004) Combination therapy in ischemic stroke: synergistic neuroprotective effects of memantine and clenbuterol. Stroke, 35, 1197-1202.
15. Dale, N. (1998) Delayed production of adenosine underlies temporal modulation of swimming in frog embryo. J. Physiol. (Lond.), 511, 265-272.
16. Dale, N., Pearson, T. & Frenguelli, B.G. (2000) Direct measurement of adenosine release during hypoxia in the CA1 region of the rat hippocampal slice. J. Physiol. (Lond.), 526, 143-155.
17. Dale, N., Gourine, A.V., Llaudet, E., Bulmer, D., Thomas, T. & Spyer, K.M. (2002) Rapid adenosine release in the nucleus tractus solitarii during defence response in rats: real-time measurement in vivo. J. Physiol. (Lond.), 544, 149-160.
18. DiGeronimo, R.J., Gegg, C.A. & Zuckerman, S.L. (1998) Adenosine depletion alters postictal hypoxic cerebral vasodilation in the newborn pig. Am. J. Physiol., 274, H1495-H1501.
19. Dirnagl, U., Simon, R.P. & Hallenbeck, J.M. (2003) Ischemic tolerance and endogenous neuroprotection. Trends Neurosci., 26, 248-254.
20. Dolphin, A.C. & Archer, E.R. (1983) An adenosine agonist inhibits and a cyclic AMP analogue enhances the release of glutamate but not GABA from slices of rat dentate gyrus. Neurosci. Lett., 43, 49-54.
21. Donello, J.E., Padillo, E.U., Webster, M.L., Wheeler, L.A. & Gil, D.W. (2001) alpha2-Adrenoceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemia. J. Pharmacol. Exp. Ther., 296, 216-223.
22. Dunwiddie, T.V. & Masino, S.A. (2001) The role and regulation of adenosine in the central nervous system. Annu. Rev. Neurosci., 24, 31-55.
23. Dunwiddie, T.V., Taylor, M., Heginbotham, L.R. & Proctor, W.R. (1992) Long-term increases in excitability in the CA1 region of rat hippocampus induced by β-adrenergic stimulation: Possible mediation by cAMP. J. Neurosci., 12, 506-517.
24. Dux, E., Fastbom, J., Ungerstedt, U., Rudolphi, K. & Fredholm, B.B. (1990) Protective effect of adenosine and a novel xanthine derivative propentofyl-line on the cell damage after bilateral carotid occlusion in the gerbil hippocampus. Brain Res., 516, 248-256.
25. Engelhard, K., Werner, C., Kaspar, S., Mollenberg, O., Blobner, M., Bachl, M. & Kochs, E. (2002) Effect of the alpha2-agonist dexmedetomidine on cerebral neurotransmitter concentrations during cerebral ischemia in rats. Anesthesiology, 96, 450-457.
26. Engelhard, K., Werner, C., Eberspacher, E., Bachl, M., Blobner, M., Hildt, E., Hutzler, P. & Kochs, E. (2003) The effect of the alpha (2)-agonist dexmedetomidine and the N-methyl-D-aspartate antagonist S(+)-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats. Anesth. Analg., 96, 524-531.
27. Fischer, W. (2002) Anticonvulsant profile and mechanism of action of propranolol and its two enantiomers. Seizure, 11, 285-302.
28. Folbergrova, J., Zhao, Q., Katsura, K. & Siesjo, B.K. (1995) N-tert-butyl-alpha-phenylnitrone improves recovery of brain energy state in rats following transient focal ischemia. Proc. Natl Acad. Sci. U.S.A., 92, 5057-5061.
29. Fowler, J.C. (1989) Adenosine antagonists delay hypoxia-induced depressions of neuronal activity in hippocampal brain slice. Brain Res., 490, 378-384.
30. Fowler, J.C. & O'Donnell, J.M. (1988) Antagonism of the responses to isoproterenol in the rat hippocampal slice with subtype-selective antagonists. Eur. J. Pharmacol., 153, 105-110.
31. Frenguelli, B.G., Llaudet, E. & Dale, N. (2003) High-resolution real-time recording with microelectrode biosensors reveals novel aspects of adenosine release during hypoxia in rat hippocampal slices. J. Neurochem., 86, 1506-1515.
32. Gao, H., Qiao, X., Cantor, L.B. & WuDunn, D. (2002) Up-regulation of brain-derived neurotrophic factor expression by brimonidine in rat retinal ganglion cells. Arch. Ophthalmol., 120, 797-803.
33. Gereau, R.W. & Conn, P.J. (1994a) Potentiation of cAMP responses by metabotropic glutamate receptors depresses excitatory synaptic transmission by a kinase-independent mechanism. Neuron, 12, 1121-1129.
34. Gereau, R.W. & Conn, P.J. (1994b) Presynaptic enhancement of excitatory synaptic transmission by β-adrenergic receptor activation. J. Neurophysiol., 72, 1438-1442.
35. Gervitz, L.M., Lutherer, L.O., Davies, D.G., Pirch, J.H. & Fowler, J.C. (2001) Adenosine induces initial hypoxic-ischemic depression of synaptic transmission in the rat hippocampus in vivo. Am. J. Physiol. Regul. Integr. Comp. Physiol., 280, R639-R645.
36. Gladstone, D.J. & Black, S.E. (2000) Enhancing recovery after stroke with noradrenergic pharmacotherapy: a new frontier? Can. J. Neurol. Sci., 27, 97-105.
37. Globus, M.Y., Busto, R., Dietrich, W.D., Martinez, E., Valdes, I. & Ginsberg, M.D. (1989) Direct evidence for acute and massive norepinephrine release in the hippocampus during transient ischemia. J. Cereb. Blood Flow Metab., 9, 892-896.
38. Gustafson, I., Westerberg, E.J. & Wieloch, T. (1991) Extracellular brain cortical levels of noradrenaline in ischemia: effects of desipramine and postischemic administration of idazoxan. Exp. Brain Res., 86, 555-561.
39. Haas, H.L. & Selbach, O. (2000) Functions of neuronal adenosine receptors. Naunyn Schmiedebergs Arch. Pharmacol., 362, 375-381.
40. Hagberg, H., Lehmann, A., Sandberg, M., Nyström, B., Jacobsen, I. & Hamberger, A. (1985) Ischemia-induced shift of inhibitory and excitatory amino acids from intra- to extracellular compartments. J. Cerebr. Blood Flow Metab., 5, 413-419.
41. Hoffman, W.E., Kochs, E., Werner, C., Thomas, C. & Albrecht, R.F. (1991) Dexmedetomidine improves neurologic outcome from incomplete ischemia in the rat. Reversal by the alpha 2-adrenergic antagonist atipamezole. Anesthesiology, 75, 328-332.
42. Houslay, M.D. & Adams, D.R. (2003) PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization. Biochem. J., 370, 1-18.
43. 1 receptor. Proc. Natl Acad. Sci. U.S.A., 98, 9407-9412.
44. Kato, H., Liu, Y., Araki, T. & Kogure, K. (1991) Temporal profile of the effects of pretreatment with brief cerebral ischemia on the neuronal damage following secondary ischemic insult in the gerbil: cumulative damage and protective effects. Brain Res., 553, 238-242.
45. Kirino, T. (2002) Ischemic tolerance. J. Cereb. Blood Flow Metab., 22, 1283-1296.
46. Kleihues, P., Kobayashi, K. & Hossmann, K.A. (1974) Purine nucleotide metabolism in the cat brain after one hour of complete ischemia. J. Neurochem., 23, 417-425.
47. Kuhmonen, J., Pokorny, J., Miettinen, R., Haapalinna, A., Jolkkonen, J., Riekkinen, P. Sr & Sivenius, J. (1997) Neuroprotective effects of dexmedetomidine in the gerbil hippocampus after transient global ischemia. Anesthesiology, 87, 371-377.
48. Laudenbach, V., Mantz, J., Lagercrantz, H., Desmonts, J.M., Evrard, P. & Gressens, P. (2002) Effects of alpha2-adrenoceptor agonists on perinatal excitotoxic brain injury: comparison of clonidine and dexmedetomidine. Anesthesiology, 96, 134-141.
49. Leker, R.R. & Shohami, E. (2002) Cerebral ischemia and trauma - different etiologies yet similar mechanisms: neuroprotective opportunities. Brain Res. Brain Res. Rev., 39, 55-73.
50. Lipton, P. (1999) Ischemic cell death in brain neurons. Physiol. Rev., 79, 1431-1568.
51. Madison, D.V. & Nicoll, R.A. (1986a) Actions of noradrenaline recorded intracellularly in rat hippocampal CA1 pyramidal neurons, in vitro. J. Physiol. (Lond.), 372, 221-244.
52. Madison, D.V. & Nicoll, R.A. (1986b) Cyclic adenosine 3′,5′-monophosphate mediates beta-receptor actions of noradrenaline in rat hippocampal pyramidal cells. J. Physiol. (Lond.), 372, 245-259.
53. Maier, C., Steinberg, G.K., Sun, G.H., Zhi, G.T. & Maze, M. (1993) Neuroprotection by the alpha 2-adrenoreceptor agonist dexmedetomidine in a focal model of cerebral ischemia. Anesthesiology, 79, 306-312.
54. Martinsson, L. & Wahlgren, N.G. (2003) Safety of dexamphetamine in acute ischemic stroke: a randomized, double-blind, controlled dose-escalation trial. Stroke, 34, 475-481.
55. Matsumoto, K., Graf, R., Rosner, G., Shimada, N. & Heiss, W.D. (1992) Flow thresholds for extracellular purine catabolite elevation in cat focal ischemia. Brain Res., 579, 309-314.
56. de Mendoņca, A. & Ribeiro, J.A. (1997) Contribution of metabotropic glutamate receptors to the depression of excitatory postsynaptic potentials during hypoxia. Neuroreport, 8, 3667-3671.
57. de Mendonça, A., Sebastiao, A.M. & Ribeiro, J.A. (2000) Adenosine: does it have a neuroprotective role after all? Brain Res. Rev., 33, 258-274.
58. 3H]noradrenaline in response to oxidative stress combined with mitochondrial dysfunction in rat hippocampal slices. Neuroscience, 120, 771-781.
59. Mueller, A.L. & Dunwiddie, T.V. (1983) Anticonvulsant and proconvulsant actions of alpha- and beta-noradrenergic agonists on epileptiform activity in rat hippocampus in vitro. Epilepsia, 24, 57-64.
60. Mynlieff, M. & Dunwiddie, T.V. (1988) Noradrenergic depression of synaptic responses in hippocampus of rat: evidence for mediation by alpha 1-receptors. Neuropharmacology, 27, 391-398.
61. 3H]noradrenaline and glutamate in response to simulation of ischemic conditions in rat spinal cord slice preparation: effect of NMDA and AMPA receptor antagonists. Eur. J. Pharmacol., 366, 143-150.
62. Nicholas, A.P., Hokfelt, T. & Pieribone, V.A. (1996) The distribution and significance of CNS adrenoceptors examined with in situ hybridization. Trends Pharmacol. Sci., 17, 245-255.
63. Onodera, H., Iijima, K. & Kogure, K. (1986) Mononucleotide metabolism in the rat brain after transient ischemia. J. Neurochem., 46, 1704-1710.
64. Pearson, T. & Frenguelli, B.G. (2000) Volume-regulated anion channels do not contribute extracellular adenosine during the hypoxic depression of excitatory synaptic transmission in area CA1 of rat hippocampus. Eur. J. Neurosci., 12, 3064-3066.
65. Pearson, T., Nuritova, F., Caldwell, D., Dale, N. & Frenguelli, B.G. (2001) A depletable pool of adenosine in area CA1 of the rat hippocampus. J. Neurosci., 21, 2298-2307.
66. Pearson, T., Currie, A.J., Etherington, L.A., Gadalla, A.E., Damian, K., Llaudet, E., Dale, N. & Frenguelli, B.G. (2003) Plasticity of purine release during cerebral ischemia: clinical implications? J. Cell Mol. Med., 7, 362-375.
67. Perego, C., Gatti, S., Vetrugno, G.C., Marzatico, F. & Algeri, S. (1992) Correlation between electroencephalogram isoelectric time and hippocampal norepinephrine levels, measured by microdialysis, during ischemia in rats. J. Neurochem., 59, 1257-1262.
68. Phillis, J.W., O'Regan, M.H., Estevez, A.Y., Song, D. & VanderHeide, S.J. (1996) Cerebral energy metabolism during severe ischemia of varying duration and following reperfusion. J. Neurochem., 67, 1525-1531.
69. Rosenberg, P.A. & Dichter, M.A. (1989) Extracellular cAMP accumulation and degradation in rat cerebral cortex in dissociated cell culture. J. Neurosci., 9, 2654-2663.
70. Rosenberg, P.A., Knowles, R., Knowles, K.P. & Li, Y. (1994) Beta-adrenergic receptor-mediated regulation of extracellular adenosine in cerebral cortex in culture. J. Neurosci., 14, 2953-2965.
71. 1 receptor in adult mice using an adeno-associated viral vector. J. Neurosci., 23, 5762-5770.
72. 3H]N6-phenylisopropyladenosine. Naunyn Schmiedebergs Arch. Pharmacol., 313, 179-187.
73. Semkova, I. & Krieglstein, J. (1999) Neuroprotection mediated via neurotrophic factors and induction of neurotrophic factors. Brain Res. Brain Res. Rev., 30, 176-188.
74. Sen, R.P., Delicado, E.G. & Miras-Portugal, M.T. (1999) Differential modulation of nucleoside transport types in neuroblastoma cells by protein kinase activation. Neuropharmacology, 38, 1009-1015.
75. Tiong, A.H. & Richardson, J.S. (1990) The characterization of beta adrenoceptor subtypes in the rat amygdala and hippocampus. Int. J. Neurosci., 54, 231-244.
76. Tomida, S., Nowak, T.S. Jr, Vass, K., Lohr, J.M. & Klatzo, I. (1987) Experimental model for repetitive ischemic attacks in the gerbil: the cumulative effect of repeated ischemic insults. J. Cereb. Blood Flow Metab., 7, 773-782.
77. Valtysson, J., Persson, L. & Hillered, L. (1998) Extracellular ischaemia markers in repeated global ischaemia and secondary hypoxaemia monitored by microdialysis in rat brain. Acta Neurochir. (Wien), 140, 387-395.
78. Vizi, E.S. (2000) Role of high-affinity receptors and membrane transporters in nonsynaptic communication and drug action in the central nervous system. Pharmacol. Rev., 52, 63-89.
79. Von Lubitz, D.K. (1999) Adenosine and cerebral ischemia: therapeutic future or death of a brave concept? Eur. J. Pharmacol., 365, 9-25.
80. Wang, L.Y., Salter, M.W. & MacDonald, J.F. (1991) Regulation of kainate receptors by cAMP-dependent protein kinase and phosphatases. Science, 253, 1132-1135.
81. Wheeler, L.A. & Woldemussie, E. (2001) Alpha-2 adrenergic receptor agonists are neuroprotective in experimental models of glaucoma. Eur. J. Ophthalmol., 11 (Suppl. 2), S30-S35.
82. Winder, D.G. & Conn, P.J. (1993) Activation of metabotropic glutamate receptors increases cAMP accumulation in hippocampus by potentiating responses to endogenous adenosine. J. Neurosci., 13, 38-44.
83. Winder, D.G., Ritch, P.S., Gereau, R.W. & Conn, P.J. (1996) Novel glial-neuronal signalling by coactivation of metabotropic glutamate and beta-adrenergic receptors in rat hippocampus. J. Physiol. (Lond.), 494, 743-755.
84. Yamamoto, T., Yamamoto, S., Osborne, J.C. Jr, Manganiello, V.C., Vaughan, M. & Hidaka, H. (1983) Complex effects of inhibitors on cyclic GMP-stimulated cyclic nucleotide phosphodiesterase. J. Biol. Chem., 258, 14 173-14 177.
85. Zhu, Y., Culmsee, C., Semkova, I. & Krieglstein, J. (1998) Stimulation of beta2-adrenoceptors inhibits apoptosis in rat brain after transient forebrain ischemia. J. Cereb. Blood Flow Metab., 18, 1032-1039.